- Filed
- Apr 7, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Feb 28, 2026 | 18.14M sh |
| Shares Diluted | Q2 2026 · Feb 28, 2026 | 18.16M sh |
| Shares Diluted | Q2 2026 · Mar 1, 2025 | 18.65M sh |
| Shares Diluted | Q2 2026 · Mar 1, 2025 | 18.65M sh |
| Stock Repurchased | Q2 2026 · Feb 28, 2026 | $32.74M |
| Stock Repurchased | Q2 2026 · Mar 1, 2025 | $12.53M |
| Dividends Paid | Q2 2026 · Feb 28, 2026 | $12.47M |
| Dividends Paid | Q2 2026 · Mar 1, 2025 | $12.15M |
| Capex | Q2 2026 · Feb 28, 2026 | $77.28M |
| Capex | Q2 2026 · Mar 1, 2025 | $66.09M |
| Operating Cash Flow | Q2 2026 · Feb 28, 2026 | $88.48M |
| Operating Cash Flow | Q2 2026 · Mar 1, 2025 | $128.3M |
| Short Term Investments | Q2 2026 · Feb 28, 2026 | $5.66M |
| Short Term Investments | Q2 2026 · Aug 30, 2025 | $5.67M |
| Cash And Equivalents | Q2 2026 · Feb 28, 2026 | $151.79M |
| Cash And Equivalents | Q2 2026 · Aug 30, 2025 | $203.5M |
| Stockholders Equity | Q2 2026 · Feb 28, 2026 | $2.18B |
| Stockholders Equity | Q2 2026 · Nov 29, 2025 | $2.16B |
| Stockholders Equity | Q2 2026 · Aug 30, 2025 | $2.17B |
| Stockholders Equity | Q2 2026 · Mar 1, 2025 | $2.14B |
| Stockholders Equity | Q2 2026 · Nov 30, 2024 | $2.13B |
| Stockholders Equity | Q2 2026 · Aug 31, 2024 | $2.11B |
| Current Liabilities | Q2 2026 · Feb 28, 2026 | $290.41M |
| Current Liabilities | Q2 2026 · Aug 30, 2025 | $290.4M |
| Total Liabilities | Q2 2026 · Feb 28, 2026 | $617.11M |
| Total Liabilities | Q2 2026 · Aug 30, 2025 | $609.2M |
| Current Assets | Q2 2026 · Feb 28, 2026 | $903.09M |
| Current Assets | Q2 2026 · Aug 30, 2025 | $924.6M |
| Total Assets | Q2 2026 · Feb 28, 2026 | $2.8B |
| Total Assets | Q2 2026 · Aug 30, 2025 | $2.78B |
| Eps Diluted | Q2 2026 · Feb 28, 2026 | $1.13 |
| Eps Diluted | Q2 2026 · Feb 28, 2026 | $3.02 |
| Eps Diluted | Q2 2026 · Mar 1, 2025 | $1.31 |
| Eps Diluted | Q2 2026 · Mar 1, 2025 | $3.62 |
| Sga Expense | Q2 2026 · Feb 28, 2026 | $157.41M |
| Sga Expense | Q2 2026 · Feb 28, 2026 | $305.22M |
| Sga Expense | Q2 2026 · Mar 1, 2025 | $141.91M |
| Sga Expense | Q2 2026 · Mar 1, 2025 | $275.43M |
| Net Income | Q2 2026 · Feb 28, 2026 | $20.48M |
| Net Income | Q2 2026 · Feb 28, 2026 | $54.85M |
| Net Income | Q2 2026 · Nov 29, 2025 | $34.36M |
| Net Income | Q2 2026 · Mar 1, 2025 | $24.46M |
| Net Income | Q2 2026 · Mar 1, 2025 | $67.56M |
| Net Income | Q2 2026 · Nov 30, 2024 | $43.11M |
| Operating Income | Q2 2026 · Feb 28, 2026 | $26.01M |
| Operating Income | Q2 2026 · Feb 28, 2026 | $71.32M |
| Operating Income | Q2 2026 · Mar 1, 2025 | $31.21M |
| Operating Income | Q2 2026 · Mar 1, 2025 | $86.75M |
| Cost Of Revenue | Q2 2026 · Feb 28, 2026 | $403.69M |
| Cost Of Revenue | Q2 2026 · Feb 28, 2026 | $796.72M |
| Cost Of Revenue | Q2 2026 · Mar 1, 2025 | $394.15M |
| Cost Of Revenue | Q2 2026 · Mar 1, 2025 | $775.2M |
| Revenue | Q2 2026 · Feb 28, 2026 | $622.51M |
| Revenue | Q2 2026 · Feb 28, 2026 | $1.24B |
| Revenue | Q2 2026 · Mar 1, 2025 | $602.22M |
| Revenue | Q2 2026 · Mar 1, 2025 | $1.21B |